| Ilya Zhuravlev, MD | |
|
24 Hospital Ave, Danbury, CT 06810-6099 | |
| (203) 797-7118 | |
| Not Available |
| Full Name | Ilya Zhuravlev |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 35 Years |
| Location | 24 Hospital Ave, Danbury, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811918584 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 043046 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary's Medical Center | San francisco, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesiologists Medical Group Of San Francisco Inc. | 8820986508 | 16 |
News Archive
Kinexus Bioinformatics Corporation, a world leader in functional proteomics research, announced the launch of a new peptide synthesis facility to provide researchers with the latest in peptide array technologies. These new services will facilitate and expedite access to peptide platforms for innovative approaches to proteomic research and discovery.
For more than half a century, products containing ion exchange resins have been used in patients with dangerously high levels of potassium. However, there is no convincing evidence that these products are actually effective, according to an article appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).
Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT) today announced it has received a $2,075 million two-year grant from the U.S. Army to study the Company's proprietary Oxycyte® PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury (TBI).
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic resistant infections, delivered four poster presentations on its Aganocide compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA.
Wednesday, April 25, marks World Malaria Day, which this year has the theme "Sustain Gains, Save Lives: Invest in Malaria." The following opinion pieces address the fight against malaria.
› Verified 4 days ago
| Entity Name | Anesthesiologists Medical Group Of San Francisco Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154379436 PECOS PAC ID: 8820986508 Enrollment ID: O20040304001382 |
News Archive
Kinexus Bioinformatics Corporation, a world leader in functional proteomics research, announced the launch of a new peptide synthesis facility to provide researchers with the latest in peptide array technologies. These new services will facilitate and expedite access to peptide platforms for innovative approaches to proteomic research and discovery.
For more than half a century, products containing ion exchange resins have been used in patients with dangerously high levels of potassium. However, there is no convincing evidence that these products are actually effective, according to an article appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).
Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT) today announced it has received a $2,075 million two-year grant from the U.S. Army to study the Company's proprietary Oxycyte® PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury (TBI).
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic resistant infections, delivered four poster presentations on its Aganocide compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA.
Wednesday, April 25, marks World Malaria Day, which this year has the theme "Sustain Gains, Save Lives: Invest in Malaria." The following opinion pieces address the fight against malaria.
› Verified 4 days ago
| Entity Name | Par Anesthesiology Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144392853 PECOS PAC ID: 1850495532 Enrollment ID: O20070406000239 |
News Archive
Kinexus Bioinformatics Corporation, a world leader in functional proteomics research, announced the launch of a new peptide synthesis facility to provide researchers with the latest in peptide array technologies. These new services will facilitate and expedite access to peptide platforms for innovative approaches to proteomic research and discovery.
For more than half a century, products containing ion exchange resins have been used in patients with dangerously high levels of potassium. However, there is no convincing evidence that these products are actually effective, according to an article appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).
Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT) today announced it has received a $2,075 million two-year grant from the U.S. Army to study the Company's proprietary Oxycyte® PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury (TBI).
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic resistant infections, delivered four poster presentations on its Aganocide compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA.
Wednesday, April 25, marks World Malaria Day, which this year has the theme "Sustain Gains, Save Lives: Invest in Malaria." The following opinion pieces address the fight against malaria.
› Verified 4 days ago
| Entity Name | Lyons Huber Anesthesia, A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619022852 PECOS PAC ID: 2062511447 Enrollment ID: O20070626000446 |
News Archive
Kinexus Bioinformatics Corporation, a world leader in functional proteomics research, announced the launch of a new peptide synthesis facility to provide researchers with the latest in peptide array technologies. These new services will facilitate and expedite access to peptide platforms for innovative approaches to proteomic research and discovery.
For more than half a century, products containing ion exchange resins have been used in patients with dangerously high levels of potassium. However, there is no convincing evidence that these products are actually effective, according to an article appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).
Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT) today announced it has received a $2,075 million two-year grant from the U.S. Army to study the Company's proprietary Oxycyte® PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury (TBI).
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic resistant infections, delivered four poster presentations on its Aganocide compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA.
Wednesday, April 25, marks World Malaria Day, which this year has the theme "Sustain Gains, Save Lives: Invest in Malaria." The following opinion pieces address the fight against malaria.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ilya Zhuravlev, MD 24 Hospital Ave, Danbury, CT 06810-6099 Ph: (203) 797-7118 | Ilya Zhuravlev, MD 24 Hospital Ave, Danbury, CT 06810-6099 Ph: (203) 797-7118 |
News Archive
Kinexus Bioinformatics Corporation, a world leader in functional proteomics research, announced the launch of a new peptide synthesis facility to provide researchers with the latest in peptide array technologies. These new services will facilitate and expedite access to peptide platforms for innovative approaches to proteomic research and discovery.
For more than half a century, products containing ion exchange resins have been used in patients with dangerously high levels of potassium. However, there is no convincing evidence that these products are actually effective, according to an article appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).
Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT) today announced it has received a $2,075 million two-year grant from the U.S. Army to study the Company's proprietary Oxycyte® PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury (TBI).
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic resistant infections, delivered four poster presentations on its Aganocide compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA.
Wednesday, April 25, marks World Malaria Day, which this year has the theme "Sustain Gains, Save Lives: Invest in Malaria." The following opinion pieces address the fight against malaria.
› Verified 4 days ago
Ellen Brand, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7118 | |
Dr. Roger Marcon, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 73 Sand Pit Rd, Danbury, CT 06810 Phone: 203-743-2400 | |
Dr. Eric Andrew Schwarz, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Department Of Anesthesiology, Danbury, CT 06810 Phone: 203-739-7118 | |
Batul Razvi, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 73 Sand Pit Rd, Danbury, CT 06810 Phone: 203-743-2400 | |
Janine Limoncelli, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7118 | |
Rogelio Sanchez, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7118 | |
Dr. Drew Cornwell, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2 Riverview Dr, Danbury, CT 06810 Phone: 203-797-1500 |